Botswana Sexual & Reproductive Health Initiative (@botssrhi) 's Twitter Profile
Botswana Sexual & Reproductive Health Initiative

@botssrhi

Botswana-based research organisation focused on improving sexual and reproductive health outcomes among women and adolescent girls

ID: 1293491388223561729

linkhttp://www.bsrhi.org calendar_today12-08-2020 10:16:44

26 Tweet

27 Followers

42 Following

IAS - the International AIDS Society (@iasociety) 's Twitter Profile Photo

Differentiated service delivery models for #HIV treatment should be leveraged to strengthen #FamilyPlanning care for women and girls. Learn more in this supplement with examples from Kenya, South Africa and Uganda: bit.ly/2H00DZA @FP2020Global

Differentiated service delivery models for #HIV treatment should be leveraged to strengthen #FamilyPlanning care for women and girls. Learn more in this supplement with examples from Kenya, South Africa and Uganda: bit.ly/2H00DZA @FP2020Global
FP2030 (@fp2030global) 's Twitter Profile Photo

‘’Only 20-43% of women with HIV in Sub-Saharan Africa use contraception. We need to do better - ART and family planning must be provided at the same appointment, and resupplies must be aligned.’’ - Dr Chelsea Morroni, IAS - the International AIDS Society

FP2030 (@fp2030global) 's Twitter Profile Photo

“We are in a moment of renewed momentum around family planning and contraceptive care for people living with #HIV. Can we capitalize on this to push for real advances in policy and funding?’’ - Dr Chelsea Morroni, IAS - the International AIDS Society bit.ly/2H00DZA

AMBITION Study (@ambitioncm2020) 's Twitter Profile Photo

Thrilled to report primary outcome of AMBITION-cm trial. Single, high-dose LAmB with 14 days 5FC + fluconazole non-inferior to WHO recommended SOC (7 days AmB + 5FC then 7 days fluco). LAmB mortality 24.8% vs 28.7% in control. Full results IAS Conference on HIV Science (Inactive account) Wednesday 21st 10:00 CET

Thrilled to report primary outcome of AMBITION-cm trial. Single, high-dose LAmB with 14 days 5FC + fluconazole non-inferior to WHO recommended SOC (7 days AmB + 5FC then 7 days fluco). LAmB mortality 24.8% vs 28.7% in control. Full results <a href="/IAS_conference/">IAS Conference on HIV Science (Inactive account)</a> Wednesday 21st 10:00 CET
Joe Jarvis (@jnjarvis76) 's Twitter Profile Photo

Today at #IAS2021 David Lawrence presents the headline results of our phase 3 AMBITION-cm trial defining a new treatment paradigm for HIV-associated cryptococcal meningitis in resource limited settings using a single high-dose liposomal ampho based regimen AMBITION Study. 1/

Today at #IAS2021 <a href="/drdavidlawrence/">David Lawrence</a> presents the headline results of our phase 3 AMBITION-cm trial defining a new treatment paradigm for HIV-associated cryptococcal meningitis in resource limited settings using a single high-dose liposomal ampho based regimen <a href="/ambitioncm2020/">AMBITION Study</a>. 1/
ISSTDR (@isstdr) 's Twitter Profile Photo

Are you passionate about digital health and STD research? Apply to be a digital ISSTDR champion by July 1st. Calling early career investigators, ppl in LMICs, and key pops. Details: isstdr.org/digital-isstdr… Nicola Low #EveryDayCounts #StillFBPE Bill Miller American Sexually Transmitted Diseases Association STD Journal STI_BMJ

Botswana Sexual & Reproductive Health Initiative (@botssrhi) 's Twitter Profile Photo

Our Nurse Coordinator, Bame Bame, representing the BSRHI team at the World AIDS Day Commemorations in Hukunsti today! #HIV #HIVAwareness #WorldAIDSDay

Our Nurse Coordinator, Bame Bame, representing the BSRHI team at the World AIDS Day Commemorations in Hukunsti today!

#HIV #HIVAwareness  #WorldAIDSDay